Investing.com - BioLineRx reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
BioLineRx announced earnings per share of $-0.2985 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.34 on revenue of $0.00.
BioLineRx shares are up 1.33% from the beginning of the year and are trading at $2.280 , down-from-52-week-high.They are under-performing the Nasdaq which is up 32.41% from the start of the year.
BioLineRx follows other major sector earnings this month
BioLineRx's report follows an earnings beat by Tencent ADR on Thursday, November 12, 2020, who reported EPS of $3.31 on revenue of $125.4B, compared to forecasts EPS of $0.47 on revenue of $18.26B.
Industrial Commercial Bank of China had beat expectations on Friday, October 30, 2020 with third quarter EPS of $0.6567 on revenue of $29.54B, compared to forecast for EPS of $0.4852 on revenue of $28.59B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar